Author

C. E. Massie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

A. Y. Warren· 2 shared A. Babbage· 1 shared A. Butler· 1 shared A. C. Riddick· 1 shared A. G. Lynch· 1 shared A. L. Riediger· 1 shared A. Lambert· 1 shared A. Matakidou· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Y. Warren

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Novel Methylation Markers in a Prostate Cancer Cohort are Associated with Disease Development and Relapse

R. P. Lach, S. Pita, W.-K. Leung, A. Babbage, S. Merson, S. Hawkins, H. Luxton, J. Kay, H. C. Whitaker, D. J. Woodcock, V. Haberland, Z. Kote-Jarai, T. Milne-Clark, K. O'Neill, T. Brendler-Spaeth, , A. G. Lynch

The paper identifies novel methylation markers in a prostate cancer cohort associated with disease development and relapse, showing their predictive power for recurrence.

bioRxiv · Aug 27, 2026 · PreprintCancer Biology

Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours

C. G. Smith, T. Moser, J. Burge, M. Eldridge, A. L. Riediger, F. Mouliere, D. Chandrananda, K. Heider, J. C. Wan, A. Y. Warren, J. Morris, I. Hudecova, W. N. Cooper, T. J. Mitchell, D. Gale, , G. D. Stewart

The paper uses sequencing methods to show that cell-free tumour DNA levels are low in renal cancer but can still be informative with improved detection strategies.

bioRxiv · Sep 11, 2019 · PreprintCancer Biology